Original Article

Up-Regulation of miR-625-5p Correlates with Suppressed Sox2, Increased Apoptosis, and Cell Cycle Arrest via The PI3K/AKT Signalling Pathway in Acute Myeloid Leukaemia

Up-Regulation of mir-625-5p and Apoptosis in the AML Cell Line

Abstract

Background: Up-regulation of the microRNA-625 and abnormal expression of the Sox2 gene have been studied and seen in several tumors. Few reports have also shown the aberrant expression of miR-625 and Sox2 expression in various cancers. Several studies have also confirmed that phosphatidylinositol 3' -kinase /protein kinase B pathways regulate hematological malignancies, including Acute Myeloid Leukemia (AML). Thus, this study aimed to investigate the effects of mir-625 up-regulation on proliferation, apoptosis, and cell cycle by targeting the Sox2 gene via the downstream Akt signaling pathway and cell cycle regulators, such as p21, p27, and cyclin E in the KG-1 cell line. 

Materials and Methods: Cells obtained from the KG-1 cell line were cultured and transfected with plasmid DNA (miR-625) and scrambled as the control using the Lonza electroporation system.  Flow cytometry was used to evaluate cell cycle, proliferation, and apoptosis. Relative gene expression was validated by qRT-PCR. All data were analyzed using graph pad prism 7.01 and REST 2009.

Results: KG-1 cells transfected with the mir625-GFP construct showed decreased proliferation, increased apoptosis, and induced cell cycle arrest. Low levels of Sox2, p21, cyclin E, and up-regulation of p27 were confirmed and validated by qRT-PCR ( P < 0.05 ).

Conclusion: MiR-625 can be a promising approach to aid in the treatment of AML. However, further studies are required in this field.

 

1. Tosic N, Petrovic I, Grujicic NK, et al. Prognostic significance of SOX2, SOX3, SOX11, SOX14 and SOX18 gene expression in adult de novo acute myeloid leukemia. Leuk Res. 2018;67:32-38.
2. Bunch H. Gene regulation of mammalian long non-coding RNA. Mol Genet Genomics. 2018;293(1):1-15.
3. Vannini I, Fanini F, Fabbri M. Emerging roles of microRNAs in cancer. Curr Opin Genet Dev. 2018;48:128-133.
4. Lou X, Qi X, Zhang Y, et al. Decreased expression of microRNA‐625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer. J Surg Oncol. 2013;108(4):230-5.
5. Wuebben EL, Rizzino A. The dark side of SOX2: cancer-a comprehensive overview. Oncotarget. 2017;8(27):44917-44943.
6. Ye W, Li J, Fang G, et al. Expression of microRNA 638 and sex-determining region Y-box 2 in hepatocellular carcinoma: Association between clinicopathological features and prognosis. Oncol Lett. 2018;15(5):7255-7264.
7. Wang Z, Qiao Q, Chen M, et al. miR-625 down-regulation promotes proliferation and invasion in esophageal cancer by targeting Sox2. FEBS Lett. 2014;588(6):915-21.
8. Fang W, Fan Y, Fa Z, et al. microRNA-625 inhibits tumorigenicity by suppressing proliferation, migration and invasion in malignant melanoma. Oncotarget. 2017;8(8):13253-13263.
9. Xin Yh, Bian Bsj, Yang Xj, et al. POU5F1 enhances the invasiveness of cancer stem-like cells in lung adenocarcinoma by upregulation of MMP-2 expression. PloS One. 2013;8(12):e83373.
10. Zhang Y, Eades G, Yao Y, et al. Estrogen receptor α signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2. J Biol Chem. 2012;287(49):41514-22.
11. Bass AJ, Watanabe H, Mermel CH, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet. 2009;41(11):1238-42.
12. Bareiss PM, Paczulla A, Wang H, et al. SOX2 expression associates with stem cell state in human ovarian carcinoma. Cancer Res. 2013;73(17):5544-55.
13. Kubota Y, Ohnishi H, Kitanaka A, et al. Constitutive activation of PI3K is involved in the spontaneous proliferation of primary acute myeloid leukemia cells: direct evidence of PI3K activation. Leukemia. 2004;18(8):1438-40.
14. Bazrafshan A, Varanlou ZD, Shahryari A, et al. Evaluation of miR-625 and miR-302a Expression in Renal Cell Carcinoma. J Pioneer Med Sci. 2018;8(2):60.
15. Aliabedi B, Mousavi SH, Ebrahimi M, et al. Hsa-miR-625 Upregulation Promotes Apoptosis in Acute Myeloid Leukemia Cell Line by Targeting Integrin-linked Kinase Pathway. Asian Pac J Cancer Prev. 2022;23(4):1159-1167.
16. Wang M, Li C, Nie H, et al. Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. FEBS Lett. 2012;586(16):2382-8.
17. Alasseiri M, Ahmed AU, Williams BR. Mechanisms and consequences of constitutive activation of integrin-linked kinase in acute myeloid leukemia. Cytokine Growth Factor Rev. 2018;43:1-7.
18. Chakraborty C, Sharma AR, Sharma G, et al. The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer. Oncotarget. 2018;9(11):10164-10174.
19. Hosseinahli N, Aghapour M, Duijf PH, et al. Treating cancer with microRNA replacement therapy: A literature review. J Cell Physiol. 2018;233(8):5574-5588.
20. Rassouli FB, Matin MM, Bahrami AR, et al. SOX2 expression in gastrointestinal cancers of Iranian patients. Int J Biol Markers. 2015;30(3):e315-20.
21. Suguna E, Farhana R, Kanimozhi E, et al. Acute myeloid leukemia: diagnosis and management based on current molecular genetics approach. Cardiovasc Hematol Disord Drug Targets. 2018;18(3):199-207.
22. Ren C, Ren T, Yang K, et al. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing’s sarcoma through the PI3K/Akt pathway. J Exp Clin Cancer Res. 2016:35:44.
23. Liao Q, Wang B, Li X, et al. miRNAs in acute myeloid leukemia. Oncotarget. 2017;8(2):3666-3682.
24. Lu Y, Futtner C, Rock JR, et al. Evidence that SOX2 overexpression is oncogenic in the lung. PloS One. 2010;5(6):e11022.
25. Nepstad I, Reikvam H, Brenner AK, et al. Resistance to the antiproliferative in vitro effect of PI3K-Akt-mTOR inhibition in primary human acute myeloid leukemia cells is associated with altered cell metabolism. Int J Mol Sci. 2018;19(2):382.
Files
IssueVol 18 No 4 (2024) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijhoscr.v18i4.16760
Keywords
Acute myeloid leukaemia; PI3K/AKT signaling pathway; miR-625; Sox2; Proliferation
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Kereka KS, Mousavi SH, Alizadeh S, Ghaemmaghami L, Fakoorizad G, Motallebzadeh Khanmiri J. Up-Regulation of miR-625-5p Correlates with Suppressed Sox2, Increased Apoptosis, and Cell Cycle Arrest via The PI3K/AKT Signalling Pathway in Acute Myeloid Leukaemia. Int J Hematol Oncol Stem Cell Res. 2024;18(4):359-367.